{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:09:59Z","timestamp":1747202999097,"version":"3.40.5"},"reference-count":21,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,9]]},"DOI":"10.20945\/2359-3997000000293","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T18:58:40Z","timestamp":1603306720000},"source":"Crossref","is-referenced-by-count":1,"title":["Importance of ELABELA in the differential diagnosis of benign and malignant lesions of the thyroid gland"],"prefix":"10.20945","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3284-2838","authenticated-orcid":false,"given":"Mehmet","family":"Bankir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8510-1748","authenticated-orcid":false,"given":"Cansu","family":"Abayli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2252-2112","authenticated-orcid":false,"given":"Fettah","family":"Acibucu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8510","reference":[{"issue":"1","key":"key20201021145838_B1","first-page":"1045","article-title":"Classification and general considerations of thyroid cancer","volume":"3","author":"Katoh","year":"2015","unstructured":"1. Katoh H, Yamashita K, Enomoto R, Watanabe M. Classification and general considerations of thyroid cancer. Ann Clin Pathol. 2015;3(1):1045.","journal-title":"Ann Clin Pathol"},{"key":"key20201021145838_B2","doi-asserted-by":"crossref","first-page":"f4706","DOI":"10.1136\/bmj.f4706","article-title":"Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours","volume":"347","author":"Brito","year":"2013","unstructured":"2. Brito JP, Morris JC, Montori VM. Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours. BMJ. 2013;347:f4706.","journal-title":"BMJ"},{"issue":"5","key":"key20201021145838_B3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJM199801293380506","article-title":"Papillary and follicular thyroid carcinoma","volume":"338","author":"Schlumberger","year":"1998","unstructured":"3. Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med. 1998;338(5):297-306.","journal-title":"N Engl J Med"},{"issue":"6","key":"key20201021145838_B4","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/00000658-200112000-00012","article-title":"Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma","volume":"234","author":"Frilling","year":"2001","unstructured":"4. Frilling A, Tecklenborg K, G\u00f6rges R, Weber F, Clausen M, Broelsch EC. Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma. Ann Surg. 2001;234(6):804-11.","journal-title":"Ann Surg"},{"issue":"3","key":"key20201021145838_B5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/thy.2005.15.251","article-title":"Distinct diagnostic criteria for ultrasonographic examination of papillary thyroid carcinoma: a multicenter study","volume":"15","author":"Shimura","year":"2005","unstructured":"5. Shimura H, Haraguchi K, Hiejima Y, Fukunari N, Fujimoto Y, Katagiri M, et al. Distinct diagnostic criteria for ultrasonographic examination of papillary thyroid carcinoma: a multicenter study. Thyroid. 2005;15(3):251-8.","journal-title":"Thyroid"},{"issue":"11","key":"key20201021145838_B6","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/thy.2009.0110","article-title":"Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer","volume":"19","author":"Cooper","year":"2009","unstructured":"6. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al.; American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167-214.","journal-title":"Thyroid"},{"issue":"11","key":"key20201021145838_B7","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1089\/thy.2009.0095","article-title":"Assessment of morphology, antigenicity, and nucleic acid integrity for diagnostic thyroid pathology using formalin substitute fixatives","volume":"19","author":"Lassalle","year":"2009","unstructured":"7. Lassalle S, Hofman V, Marius I, Gavric-Tanga V, Brest P, Havet K, et al. Assessment of morphology, antigenicity, and nucleic acid integrity for diagnostic thyroid pathology using formalin substitute fixatives. Thyroid. 2009;19(11):1239-48.","journal-title":"Thyroid"},{"issue":"2","key":"key20201021145838_B8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12022-018-9532-9","article-title":"Immunohistochemical biomarkers in thyroid pathology","volume":"29","author":"Baloch","year":"2018","unstructured":"8. Baloch Z, Mete O, Asa SL. Immunohistochemical biomarkers in thyroid pathology. Endocr Pathol. 2018;29(2):91-112.","journal-title":"Endocr Pathol"},{"issue":"9","key":"key20201021145838_B9","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.tips.2015.06.002","article-title":"Apelin, Elabela\/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system","volume":"36","author":"Yang","year":"2015","unstructured":"9. Yang P, Maguire JJ, Davenport AP. Apelin, Elabela\/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system. Trends Pharmacol Sci. 2015;36(9):560-7.","journal-title":"Trends Pharmacol Sci"},{"key":"key20201021145838_B10","doi-asserted-by":"crossref","first-page":"8170","DOI":"10.1038\/srep08170","article-title":"Elabela-apelin receptor signaling pathway is functional in mammalian systems","volume":"5","author":"Wang","year":"2015","unstructured":"10. Wang Z, Yu D, Wang M, Wang Q, Kouznetsova J, Yang R, et al. Elabela-apelin receptor signaling pathway is functional in mammalian systems. Sci Rep. 2015;5:8170.","journal-title":"Sci Rep"},{"key":"key20201021145838_B11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.preghy.2019.06.007","article-title":"Is ELABELA a reliable biomarker for hypertensive disorders of pregnancy?","volume":"17","author":"Huang","year":"2019","unstructured":"11. Huang R, Zhu J, Zhang L, Hua X, Ye W, Chen C, et al. Is ELABELA a reliable biomarker for hypertensive disorders of pregnancy? Pregnancy Hypertens. 2019;17:226-32.","journal-title":"Pregnancy Hypertens"},{"issue":"6","key":"key20201021145838_B12","first-page":"989","article-title":"A novel candidate molecule in the pathological grading of gliomas: ELABELA","volume":"28","author":"Artas","year":"2018","unstructured":"12. Artas G, Ozturk S, Kuloglu T, Dagli AF, Gonen M, Artas H, et al. A novel candidate molecule in the pathological grading of gliomas: ELABELA. Turk Neurosurg. 2018;28(6):989-94.","journal-title":"Turk Neurosurg"},{"issue":"3","key":"key20201021145838_B13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4103\/njcp.njcp_105_18","article-title":"A promising biomarker to distinguish benign and malignant renal tumors: ELABELA","volume":"22","author":"Artas","year":"2019","unstructured":"13. Artas G, Kuloglu T, Dagli AF, Ugur K, Yardim M, Aydin S, et al. A promising biomarker to distinguish benign and malignant renal tumors: ELABELA. Niger J Clin Pract. 2019;22(3):386-92.","journal-title":"Niger J Clin Pract"},{"issue":"6352","key":"key20201021145838_B14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.aam6607","article-title":"ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice","volume":"357","author":"Ho","year":"2017","unstructured":"14. Ho L, van Dijk M, Chye STJ, Messerschmidt DM, Chng SC, Ong S, et al. ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice. Science. 2017;357(6352):707-13.","journal-title":"Science"},{"issue":"6","key":"key20201021145838_B15","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.devcel.2013.11.002","article-title":"ELABELA: a hormone essential for heart development signals via the apelin receptor","volume":"27","author":"Chng","year":"2013","unstructured":"15. Chng SC, Ho L, Tian J, Reversade B. ELABELA: a hormone essential for heart development signals via the apelin receptor. Dev Cell. 2013;27(6):672-80.","journal-title":"Dev Cell"},{"issue":"3","key":"key20201021145838_B16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.regpep.2004.10.019","article-title":"Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells","volume":"126","author":"Kleinz","year":"2005","unstructured":"16. Kleinz MJ, Skepper JN, Davenport AP. Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells. Regul Pept. 2005;126(3):233-40.","journal-title":"Regul Pept"},{"issue":"8","key":"key20201021145838_B17","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ejheart.2008.06.002","article-title":"The role of apelin in cardiovascular function and heart failure","volume":"10","author":"Chandrasekaran","year":"2008","unstructured":"17. Chandrasekaran B, Dar O, McDonagh T. The role of apelin in cardiovascular function and heart failure. Eur J Heart Fail. 2008;10(8):725-32.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"key20201021145838_B18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.regpep.2003.11.002","article-title":"Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells","volume":"118","author":"Kleinz","year":"2004","unstructured":"18. Kleinz MJ, Davenport AP. Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells. Regul Pept. 2004;118(3):119-25.","journal-title":"Regul Pept"},{"issue":"6","key":"key20201021145838_B19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2174\/138161212799277770","article-title":"Apelin in the control of body fluid homeostasis and cardiovascular functions","volume":"18","author":"Galanth","year":"2012","unstructured":"19. Galanth C, Hus-Citharel A, Li B, Llorens-Cort\u00e8s C. Apelin in the control of body fluid homeostasis and cardiovascular functions. Curr Pharm Des. 2012;18(6):789-98.","journal-title":"Curr Pharm Des"},{"issue":"5","key":"key20201021145838_B20","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1046\/j.1471-4159.2003.01587.x","article-title":"Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin","volume":"84","author":"Medhurst","year":"2003","unstructured":"20. Medhurst AD, Jennings CA, Robbins MJ, Davis RP, Ellis C, Winborn KY, et al. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J Neurochem. 2003;84(5):1162-72.","journal-title":"J Neurochem"},{"issue":"6","key":"key20201021145838_B21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1139\/bcb-2014-0072","article-title":"The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR","volume":"92","author":"Chapman","year":"2014","unstructured":"21. Chapman NA, Dupr\u00e9 DJ, Rainey JK. The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR. Biochem Cell Biol. 2014;92(6):431-40.","journal-title":"Biochem Cell Biol"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T08:36:28Z","timestamp":1696926988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2359-39972020005007202&lng=en&nrm=iso"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":21,"alternative-id":["10.20945\/2359-3997000000293"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000293","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"type":"print","value":"2359-3997"},{"type":"electronic","value":"2359-4292"}],"subject":[],"published":{"date-parts":[[2020,10,9]]}}}